Request for Covid-19 Impact Assessment of this Report

Medical Devices

United States Insulin Delivery Devices Market Report 2017

  • QYR1537162
  • 113 Pages
  • September 2017
  • Medical Devices
Download Sample    Get Discount   
 
In this report, the United States Insulin Delivery Devices market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:

The West

Southwest

The Middle Atlantic

New England

The South

The Midwest

with sales (volume), revenue (value), market share and growth rate of Insulin Delivery Devices in these regions, from 2012 to 2022 (forecast).

United States Insulin Delivery Devices market competition by top manufacturers/players, with Insulin Delivery Devices sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

Medtronic, Inc.

Becton

F. Hoffmann-La Roche

Abbott Laboratories

Novo Nordisk A/S

Eli Lilly and Company

Sanofi

Becton Dickinson

Insulet

B. Braun Melsungen AG

Animas Corporation

Ypsomed Holdings AG

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

Insulin Pens (Reusable, Disposable)

Insulin Pumps (External/Tethered, Patch)

Pen Needles (Standard, Safety)

Insulin Syringes

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Insulin Delivery Devices for each application, including

Patients/Homecare

Hospitals & Clinics

If you have any special requirements, please let us know and we will offer you the report as you want.

Table of Contents

United States Insulin Delivery Devices Market Report 2017

1 Insulin Delivery Devices Overview

1.1 Product Overview and Scope of Insulin Delivery Devices

1.2 Classification of Insulin Delivery Devices by Product Category

1.2.1 United States Insulin Delivery Devices Market Size (Sales Volume) Comparison by Type (2012-2022)

1.2.2 United States Insulin Delivery Devices Market Size (Sales Volume) Market Share by Type (Product Category) in 2016

1.2.3 Insulin Pens (Reusable, Disposable)

1.2.4 Insulin Pumps (External/Tethered, Patch)

1.2.5 Pen Needles (Standard, Safety)

1.2.6 Insulin Syringes

1.3 United States Insulin Delivery Devices Market by Application/End Users

1.3.1 United States Insulin Delivery Devices Market Size (Consumption) and Market Share Comparison by Application (2012-2022)

1.3.2 Patients/Homecare

1.3.3 Hospitals & Clinics

1.4 United States Insulin Delivery Devices Market by Region

1.4.1 United States Insulin Delivery Devices Market Size (Value) Comparison by Region (2012-2022)

1.4.2 The West Insulin Delivery Devices Status and Prospect (2012-2022)

1.4.3 Southwest Insulin Delivery Devices Status and Prospect (2012-2022)

1.4.4 The Middle Atlantic Insulin Delivery Devices Status and Prospect (2012-2022)

1.4.5 New England Insulin Delivery Devices Status and Prospect (2012-2022)

1.4.6 The South Insulin Delivery Devices Status and Prospect (2012-2022)

1.4.7 The Midwest Insulin Delivery Devices Status and Prospect (2012-2022)

1.5 United States Market Size (Value and Volume) of Insulin Delivery Devices (2012-2022)

1.5.1 United States Insulin Delivery Devices Sales and Growth Rate (2012-2022)

1.5.2 United States Insulin Delivery Devices Revenue and Growth Rate (2012-2022)

2 United States Insulin Delivery Devices Market Competition by Players/Suppliers

2.1 United States Insulin Delivery Devices Sales and Market Share of Key Players/Suppliers (2012-2017)

2.2 United States Insulin Delivery Devices Revenue and Share by Players/Suppliers (2012-2017)

2.3 United States Insulin Delivery Devices Average Price by Players/Suppliers (2012-2017)

2.4 United States Insulin Delivery Devices Market Competitive Situation and Trends

2.4.1 United States Insulin Delivery Devices Market Concentration Rate

2.4.2 United States Insulin Delivery Devices Market Share of Top 3 and Top 5 Players/Suppliers

2.4.3 Mergers & Acquisitions, Expansion in United States Market

2.5 United States Players/Suppliers Insulin Delivery Devices Manufacturing Base Distribution, Sales Area, Product Type

3 United States Insulin Delivery Devices Sales (Volume) and Revenue (Value) by Region (2012-2017)

3.1 United States Insulin Delivery Devices Sales and Market Share by Region (2012-2017)

3.2 United States Insulin Delivery Devices Revenue and Market Share by Region (2012-2017)

3.3 United States Insulin Delivery Devices Price by Region (2012-2017)

4 United States Insulin Delivery Devices Sales (Volume) and Revenue (Value) by Type (Product Category) (2012-2017)

4.1 United States Insulin Delivery Devices Sales and Market Share by Type (Product Category) (2012-2017)

4.2 United States Insulin Delivery Devices Revenue and Market Share by Type (2012-2017)

4.3 United States Insulin Delivery Devices Price by Type (2012-2017)

4.4 United States Insulin Delivery Devices Sales Growth Rate by Type (2012-2017)

5 United States Insulin Delivery Devices Sales (Volume) by Application (2012-2017)

5.1 United States Insulin Delivery Devices Sales and Market Share by Application (2012-2017)

5.2 United States Insulin Delivery Devices Sales Growth Rate by Application (2012-2017)

5.3 Market Drivers and Opportunities

6 United States Insulin Delivery Devices Players/Suppliers Profiles and Sales Data

6.1 Medtronic, Inc.

6.1.1 Company Basic Information, Manufacturing Base and Competitors

6.1.2 Insulin Delivery Devices Product Category, Application and Specification

6.1.2.1 Product A

6.1.2.2 Product B

6.1.3 Medtronic, Inc. Insulin Delivery Devices Sales, Revenue, Price and Gross Margin (2012-2017)

6.1.4 Main Business/Business Overview

6.2 Becton

6.2.2 Insulin Delivery Devices Product Category, Application and Specification

6.2.2.1 Product A

6.2.2.2 Product B

6.2.3 Becton Insulin Delivery Devices Sales, Revenue, Price and Gross Margin (2012-2017)

6.2.4 Main Business/Business Overview

6.3 F. Hoffmann-La Roche

6.3.2 Insulin Delivery Devices Product Category, Application and Specification

6.3.2.1 Product A

6.3.2.2 Product B

6.3.3 F. Hoffmann-La Roche Insulin Delivery Devices Sales, Revenue, Price and Gross Margin (2012-2017)

6.3.4 Main Business/Business Overview

6.4 Abbott Laboratories

6.4.2 Insulin Delivery Devices Product Category, Application and Specification

6.4.2.1 Product A

6.4.2.2 Product B

6.4.3 Abbott Laboratories Insulin Delivery Devices Sales, Revenue, Price and Gross Margin (2012-2017)

6.4.4 Main Business/Business Overview

6.5 Novo Nordisk A/S

6.5.2 Insulin Delivery Devices Product Category, Application and Specification

6.5.2.1 Product A

6.5.2.2 Product B

6.5.3 Novo Nordisk A/S Insulin Delivery Devices Sales, Revenue, Price and Gross Margin (2012-2017)

6.5.4 Main Business/Business Overview

6.6 Eli Lilly and Company

6.6.2 Insulin Delivery Devices Product Category, Application and Specification

6.6.2.1 Product A

6.6.2.2 Product B

6.6.3 Eli Lilly and Company Insulin Delivery Devices Sales, Revenue, Price and Gross Margin (2012-2017)

6.6.4 Main Business/Business Overview

6.7 Sanofi

6.7.2 Insulin Delivery Devices Product Category, Application and Specification

6.7.2.1 Product A

6.7.2.2 Product B

6.7.3 Sanofi Insulin Delivery Devices Sales, Revenue, Price and Gross Margin (2012-2017)

6.7.4 Main Business/Business Overview

6.8 Becton Dickinson

6.8.2 Insulin Delivery Devices Product Category, Application and Specification

6.8.2.1 Product A

6.8.2.2 Product B

6.8.3 Becton Dickinson Insulin Delivery Devices Sales, Revenue, Price and Gross Margin (2012-2017)

6.8.4 Main Business/Business Overview

6.9 Insulet

6.9.2 Insulin Delivery Devices Product Category, Application and Specification

6.9.2.1 Product A

6.9.2.2 Product B

6.9.3 Insulet Insulin Delivery Devices Sales, Revenue, Price and Gross Margin (2012-2017)

6.9.4 Main Business/Business Overview

6.10 B. Braun Melsungen AG

6.10.2 Insulin Delivery Devices Product Category, Application and Specification

6.10.2.1 Product A

6.10.2.2 Product B

6.10.3 B. Braun Melsungen AG Insulin Delivery Devices Sales, Revenue, Price and Gross Margin (2012-2017)

6.10.4 Main Business/Business Overview

6.11 Animas Corporation

6.12 Ypsomed Holdings AG

7 Insulin Delivery Devices Manufacturing Cost Analysis

7.1 Insulin Delivery Devices Key Raw Materials Analysis

7.1.1 Key Raw Materials

7.1.2 Price Trend of Key Raw Materials

7.1.3 Key Suppliers of Raw Materials

7.1.4 Market Concentration Rate of Raw Materials

7.2 Proportion of Manufacturing Cost Structure

7.2.1 Raw Materials

7.2.2 Labor Cost

7.2.3 Manufacturing Expenses

7.3 Manufacturing Process Analysis of Insulin Delivery Devices

8 Industrial Chain, Sourcing Strategy and Downstream Buyers

8.1 Insulin Delivery Devices Industrial Chain Analysis

8.2 Upstream Raw Materials Sourcing

8.3 Raw Materials Sources of Insulin Delivery Devices Major Manufacturers in 2016

8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders

9.1 Marketing Channel

9.1.1 Direct Marketing

9.1.2 Indirect Marketing

9.1.3 Marketing Channel Development Trend

9.2 Market Positioning

9.2.1 Pricing Strategy

9.2.2 Brand Strategy

9.2.3 Target Client

9.3 Distributors/Traders List

10 Market Effect Factors Analysis

10.1 Technology Progress/Risk

10.1.1 Substitutes Threat

10.1.2 Technology Progress in Related Industry

10.2 Consumer Needs/Customer Preference Change

10.3 Economic/Political Environmental Change

11 United States Insulin Delivery Devices Market Size (Value and Volume) Forecast (2017-2022)

11.1 United States Insulin Delivery Devices Sales Volume, Revenue Forecast (2017-2022)

11.2 United States Insulin Delivery Devices Sales Volume Forecast by Type (2017-2022)

11.3 United States Insulin Delivery Devices Sales Volume Forecast by Application (2017-2022)

11.4 United States Insulin Delivery Devices Sales Volume Forecast by Region (2017-2022)

12 Research Findings and Conclusion

13 Appendix

13.1 Methodology/Research Approach

13.1.1 Research Programs/Design

13.1.2 Market Size Estimation

13.1.3 Market Breakdown and Data Triangulation

13.2 Data Source

13.2.1 Secondary Sources

13.2.2 Primary Sources

13.3 Disclaimer

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

Medical Implants Market By Type (Orthopedic Implants, cardiac implants, Stents, Spinal Implants, Neurostimulators, dental implants, Breast Implants, facial Implants) and By Materials (Metallic, Ceramic, Polymers, Natural) - Global Opportunity Analysis and Industry Forecast, 2014 - 2022

Medical implants are permanent devices such as pacemakers or temporary devices such as fracture plates which are removed once their function is completed. These implants are made up of bone, tissue, skin, ceramics, metals, plastics, and other natural materials...

  • Publish Date: August 21, 2016
  • $5370
Ostomy Drainage Bags Market by Type (Colostomy Bags, Ileostomy Bags, Urostomy Bags, Continent Urostomy Bags, and Continent Ileostomy Bags) - Global Opportunity Analysis and Industry Forecast, 2014-2022

Ostomy is a surgery wherein an artificial opening, known as stoma, is created from the colon in the human body to eliminate body wastes such as urine, mucus, and stools, which are collected in artificial bags called ostomy drainage bags. These plastic/rub...

  • Publish Date: December 1, 2016
  • $5370